Lincomycin

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BOD072YW0F, chemically known as lincolnensin, hydrochloride, hemihydrate but generally known as lincomycin, which bears US NIH Compound Identifier 3928. European Medicines Agency schedules Lincomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08517MIG. The term LINCOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules lincomycin in its Anatomical Therapeutic Chemical (ATC) Classification. LINCOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lincomycin under HS 29419000 and SITC 54139. As of Q4 2014, LINCOMYCIN remains the US FDA Preferred Term for this commodity. Lincomycin bears US NLM identifiers UMLS ID C0023726 and NCI Concept Code C61811. SMILES: S(C1OC(C(NC(=O)C2N(CC(C2)CCC)C)C(O)C)C(O)C(O)C1O)C.